Semiconductors
Compare Stocks
5 / 10Stock Comparison
TRT vs ACLS vs ONTO vs UCTT vs ICHR
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
TRT vs ACLS vs ONTO vs UCTT vs ICHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $108M | $5.01B | $14.16B | $3.96B | $2.59B |
| Revenue (TTM) | $49M | $845M | $1.03B | $2.07B | $959M |
| Net Income (TTM) | $-109K | $101M | $106M | $-194M | $-51M |
| Gross Margin | 19.7% | 43.6% | 48.8% | 15.6% | 11.3% |
| Operating Margin | 0.5% | 11.6% | 10.0% | -5.3% | -3.8% |
| Forward P/E | — | 44.7x | 39.9x | 37.5x | 54.0x |
| Total Debt | $2M | $42M | $17M | $810M | $186M |
| Cash & Equiv. | $11M | $145M | $346M | $312M | $98M |
TRT vs ACLS vs ONTO vs UCTT vs ICHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Trio-Tech Internati… (TRT) | 100 | 434.2 | +334.2% |
| Axcelis Technologie… (ACLS) | 100 | 607.2 | +507.2% |
| Onto Innovation Inc. (ONTO) | 100 | 915.9 | +815.9% |
| Ultra Clean Holding… (UCTT) | 100 | 420.2 | +320.2% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 327.1 | +227.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TRT vs ACLS vs ONTO vs UCTT vs ICHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TRT ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.61
- Lower volatility, beta 0.61, Low D/E 5.1%, current ratio 5.03x
- Beta 0.61, current ratio 5.03x
- Beta 0.61 vs ICHR's 3.78, lower leverage
ACLS has the current edge in this matchup, primarily because of its strength in long-term compounding.
- 15.5% 10Y total return vs ONTO's 14.9%
- 11.9% margin vs UCTT's -9.4%
- 7.5% ROA vs UCTT's -11.0%, ROIC 9.6% vs 2.6%
ONTO is the clearest fit if your priority is growth exposure and valuation efficiency.
- Rev growth 1.8%, EPS growth -31.5%, 3Y rev CAGR 0.0%
- PEG 1.16 vs ACLS's 2.12
- Lower P/E (39.9x vs 54.0x)
Among these 5 stocks, UCTT doesn't own a clear edge in any measured category.
ICHR is the #2 pick in this set and the best alternative if growth and momentum is your priority.
- 11.6% revenue growth vs ACLS's -17.6%
- +345.1% vs ONTO's +124.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.6% revenue growth vs ACLS's -17.6% | |
| Value | Lower P/E (39.9x vs 54.0x) | |
| Quality / Margins | 11.9% margin vs UCTT's -9.4% | |
| Stability / Safety | Beta 0.61 vs ICHR's 3.78, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +345.1% vs ONTO's +124.5% | |
| Efficiency (ROA) | 7.5% ROA vs UCTT's -11.0%, ROIC 9.6% vs 2.6% |
TRT vs ACLS vs ONTO vs UCTT vs ICHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
TRT vs ACLS vs ONTO vs UCTT vs ICHR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TRT leads in 1 of 6 categories
ACLS leads 1 • ONTO leads 1 • UCTT leads 0 • ICHR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — ACLS and ONTO each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UCTT is the larger business by revenue, generating $2.1B annually — 42.0x TRT's $49M. ACLS is the more profitable business, keeping 11.9% of every revenue dollar as net income compared to UCTT's -9.4%. On growth, TRT holds the edge at +81.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $49M | $845M | $1.0B | $2.1B | $959M |
| EBITDAEarnings before interest/tax | $3M | $111M | $158M | -$52M | -$11M |
| Net IncomeAfter-tax profit | -$109,000 | $101M | $106M | -$194M | -$51M |
| Free Cash FlowCash after capex | $137,000 | $90M | $239M | -$44M | -$17M |
| Gross MarginGross profit ÷ Revenue | +19.7% | +43.6% | +48.8% | +15.6% | +11.3% |
| Operating MarginEBIT ÷ Revenue | +0.5% | +11.6% | +10.0% | -5.3% | -3.8% |
| Net MarginNet income ÷ Revenue | -0.2% | +11.9% | +10.3% | -9.4% | -5.3% |
| FCF MarginFCF ÷ Revenue | +0.3% | +10.7% | +23.2% | -2.1% | -1.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +81.6% | +3.3% | +9.5% | +2.9% | +4.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -76.0% | -65.9% | -48.5% | -2.6% | +46.2% |
Valuation Metrics
TRT leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 42.9x trailing earnings, ACLS trades at a 58% valuation discount to ONTO's 102.4x P/E. Adjusting for growth (PEG ratio), ACLS offers better value at 2.03x vs ONTO's 2.96x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $108M | $5.0B | $14.2B | $4.0B | $2.6B |
| Enterprise ValueMkt cap + debt − cash | $99M | $4.9B | $13.8B | $4.5B | $2.7B |
| Trailing P/EPrice ÷ TTM EPS | -2568.75x | 42.90x | 102.40x | -21.77x | -48.32x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 44.69x | 39.93x | 37.54x | 53.98x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.03x | 2.96x | — | — |
| EV / EBITDAEnterprise value multiple | 32.91x | 35.83x | 71.53x | 37.27x | — |
| Price / SalesMarket cap ÷ Revenue | 2.95x | 5.97x | 14.09x | 1.93x | 2.73x |
| Price / BookPrice ÷ Book value/share | 3.17x | 4.99x | 6.68x | 5.03x | 3.84x |
| Price / FCFMarket cap ÷ FCF | — | 46.82x | 47.23x | 269.54x | — |
Profitability & Efficiency
ACLS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ACLS delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-25 for UCTT. ONTO carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to UCTT's 1.03x. On the Piotroski fundamental quality scale (0–9), ACLS scores 5/9 vs ICHR's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -0.3% | +9.8% | +5.2% | -25.4% | -7.5% |
| ROA (TTM)Return on assets | -0.2% | +7.5% | +4.7% | -11.0% | -5.2% |
| ROICReturn on invested capital | +0.8% | +9.6% | +5.7% | +2.6% | -3.9% |
| ROCEReturn on capital employed | +0.7% | +10.4% | +6.5% | +2.9% | -4.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 4 | 5 | 3 |
| Debt / EquityFinancial leverage | 0.05x | 0.04x | 0.01x | 1.03x | 0.28x |
| Net DebtTotal debt minus cash | -$9M | -$103M | -$329M | $499M | $87M |
| Cash & Equiv.Liquid assets | $11M | $145M | $346M | $312M | $98M |
| Total DebtShort + long-term debt | $2M | $42M | $17M | $810M | $186M |
| Interest CoverageEBIT ÷ Interest expense | 0.57x | 82.78x | — | -5.80x | -5.97x |
Total Returns (Dividends Reinvested)
ONTO leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ONTO five years ago would be worth $46,041 today (with dividends reinvested), compared to $14,598 for ICHR. Over the past 12 months, ICHR leads with a +345.1% total return vs ONTO's +124.5%. The 3-year compound annual growth rate (CAGR) favors ONTO at 48.9% vs ACLS's 10.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -1.0% | +89.3% | +71.6% | +218.8% | +264.6% |
| 1-Year ReturnPast 12 months | +130.5% | +177.0% | +124.5% | +332.5% | +345.1% |
| 3-Year ReturnCumulative with dividends | +186.4% | +35.8% | +230.4% | +213.4% | +162.3% |
| 5-Year ReturnCumulative with dividends | +148.6% | +321.3% | +360.4% | +84.0% | +46.0% |
| 10-Year ReturnCumulative with dividends | +270.2% | +1550.1% | +1491.2% | +1519.0% | +661.7% |
| CAGR (3Y)Annualised 3-year return | +42.0% | +10.7% | +48.9% | +46.3% | +37.9% |
Risk & Volatility
Evenly matched — TRT and UCTT each lead in 1 of 2 comparable metrics.
Risk & Volatility
TRT is the less volatile stock with a 0.61 beta — it tends to amplify market swings less than ICHR's 3.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UCTT currently trades 99.3% from its 52-week high vs TRT's 64.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.61x | 2.17x | 2.60x | 3.21x | 3.78x |
| 52-Week HighHighest price in past year | $19.10 | $171.60 | $315.86 | $87.68 | $75.35 |
| 52-Week LowLowest price in past year | $4.42 | $55.93 | $85.88 | $18.93 | $13.12 |
| % of 52W HighCurrent price vs 52-week peak | +64.6% | +95.0% | +90.1% | +99.3% | +98.8% |
| RSI (14)Momentum oscillator 0–100 | 54.8 | 70.9 | 51.2 | 57.0 | 64.2 |
| Avg Volume (50D)Average daily shares traded | 1.0M | 735K | 827K | 1.2M | 791K |
Analyst Outlook
Evenly matched — UCTT and ICHR each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: ACLS as "Buy", ONTO as "Buy", UCTT as "Buy", ICHR as "Buy". Consensus price targets imply 16.5% upside for ONTO (target: $332) vs -26.6% for ICHR (target: $55).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $128.00 | $331.67 | $100.00 | $54.60 |
| # AnalystsCovering analysts | — | 12 | 11 | 12 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | — | 1 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.4% | +0.5% | +0.1% | 0.0% |
TRT leads in 1 of 6 categories (Valuation Metrics). ACLS leads in 1 (Profitability & Efficiency). 3 tied.
TRT vs ACLS vs ONTO vs UCTT vs ICHR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TRT or ACLS or ONTO or UCTT or ICHR a better buy right now?
For growth investors, Ichor Holdings, Ltd.
(ICHR) is the stronger pick with 11. 6% revenue growth year-over-year, versus -17. 6% for Axcelis Technologies, Inc. (ACLS). Axcelis Technologies, Inc. (ACLS) offers the better valuation at 42. 9x trailing P/E (44. 7x forward), making it the more compelling value choice. Analysts rate Axcelis Technologies, Inc. (ACLS) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TRT or ACLS or ONTO or UCTT or ICHR?
On trailing P/E, Axcelis Technologies, Inc.
(ACLS) is the cheapest at 42. 9x versus Onto Innovation Inc. at 102. 4x. On forward P/E, Ultra Clean Holdings, Inc. is actually cheaper at 37. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Onto Innovation Inc. wins at 1. 16x versus Axcelis Technologies, Inc. 's 2. 12x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — TRT or ACLS or ONTO or UCTT or ICHR?
Over the past 5 years, Onto Innovation Inc.
(ONTO) delivered a total return of +360. 4%, compared to +46. 0% for Ichor Holdings, Ltd. (ICHR). Over 10 years, the gap is even starker: ACLS returned +1550% versus TRT's +270. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TRT or ACLS or ONTO or UCTT or ICHR?
By beta (market sensitivity over 5 years), Trio-Tech International (TRT) is the lower-risk stock at 0.
61β versus Ichor Holdings, Ltd. 's 3. 78β — meaning ICHR is approximately 522% more volatile than TRT relative to the S&P 500. On balance sheet safety, Onto Innovation Inc. (ONTO) carries a lower debt/equity ratio of 1% versus 103% for Ultra Clean Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TRT or ACLS or ONTO or UCTT or ICHR?
By revenue growth (latest reported year), Ichor Holdings, Ltd.
(ICHR) is pulling ahead at 11. 6% versus -17. 6% for Axcelis Technologies, Inc. (ACLS). On earnings-per-share growth, the picture is similar: Onto Innovation Inc. grew EPS -31. 5% year-over-year, compared to -869. 2% for Ultra Clean Holdings, Inc.. Over a 3-year CAGR, ONTO leads at 0. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TRT or ACLS or ONTO or UCTT or ICHR?
Axcelis Technologies, Inc.
(ACLS) is the more profitable company, earning 14. 3% net margin versus -8. 8% for Ultra Clean Holdings, Inc. — meaning it keeps 14. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACLS leads at 14. 2% versus -4. 1% for ICHR. At the gross margin level — before operating expenses — ONTO leads at 49. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TRT or ACLS or ONTO or UCTT or ICHR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Onto Innovation Inc. (ONTO) is the more undervalued stock at a PEG of 1. 16x versus Axcelis Technologies, Inc. 's 2. 12x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Ultra Clean Holdings, Inc. (UCTT) trades at 37. 5x forward P/E versus 54. 0x for Ichor Holdings, Ltd. — 16. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ONTO: 16. 5% to $331. 67.
08Which pays a better dividend — TRT or ACLS or ONTO or UCTT or ICHR?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is TRT or ACLS or ONTO or UCTT or ICHR better for a retirement portfolio?
For long-horizon retirement investors, Trio-Tech International (TRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
61), +270. 2% 10Y return). Ichor Holdings, Ltd. (ICHR) carries a higher beta of 3. 78 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TRT: +270. 2%, ICHR: +661. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TRT and ACLS and ONTO and UCTT and ICHR?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.